Back

Statin treatment after acute coronary syndrome: long-term persistence and reasons for non-persistence

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Preventive cardiology / Lipids Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Daniel Huber

Umea University, Umea (Sweden)

20 More presentations in this session

Presentation thumbnail
Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease
Doctor I. Dykun (Essen, DE)
Abstract
Presentation thumbnail
Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular- and all-cause mortality in chronic haemodialysis patients
Doctor Y. Kumada (Kasamatsu, JP)
Abstract
Presentation thumbnail
The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris
Doctor G. Svingen (Bergen, NO)
Abstract
Presentation thumbnail
Post-prandial remnant lipoprotein metabolism in sitosterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract
Presentation thumbnail
PEARL, a non-interventional study on real-world use of alirocumab in German clinical practice: final study and cardiovascular subgroup data
Professor K. Parhofer (Munich, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Preventive cardiology / Lipids

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Lipidomics to fine-tune cardiovascular risk prediction and personalised treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources